| 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2014 ( ₹ in Cr. ) | |
|---|---|---|---|---|
| INCOME : | ||||
| Sales Turnover | 359.73 | 400.19 | 560.53 | 666.95 |
| Other Income | 5.5 | 3.98 | 7.85 | 3.68 |
| Stock Adjustments | -13.63 | -14.85 | 89.93 | 152.33 |
| Total Income | 351.6 | 389.32 | 658.31 | 822.96 |
| EXPENDITURE : | ||||
| Raw Materials | 237.87 | 258.61 | 444.37 | 617.84 |
| Excise Duty | 7.39 | 31.76 | 36.54 | 0 |
| Power and Fuel Cost | 0 | 0 | 0 | 0 |
| Other Manufacturing Expenses | 8.35 | 6.7 | 10.9 | 7.69 |
| Employee Cost | 58.41 | 54.41 | 66.11 | 51.67 |
| Selling and Administration Expenses | 19.96 | 21.28 | 28.08 | 30.83 |
| Miscellaneous Expenses | 772.29 | 0 | 0 | 31.32 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -752.7 | 16.55 | 72.3 | 83.6 |
| Interest and Financial Charges | 439.67 | 369.8 | 414.78 | 469.51 |
| Profit before Depreciation and Tax | -1192.37 | -353.25 | -342.48 | -385.91 |
| Depreciation | 245.75 | 263.55 | 345.14 | 276.57 |
| Profit Before Tax | -1438.12 | -616.8 | -687.62 | -662.49 |
| Tax | -432.73 | -204.34 | -237.15 | -204.78 |
| Profit After Tax | -1005.39 | -412.46 | -450.47 | -457.71 |
| Adjustment below Net Profit | 0 | -0.01 | 0 | 0 |
| P and L Balance brought forward | -903.1 | -490.64 | -40.17 | 0 |
| Appropriations | 0 | 0 | 0 | -417.54 |
| P and L Bal. carried down | -1908.49 | -903.1 | -490.64 | -40.17 |
| Equity Dividend | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 |
| Book Value | 10.14 | 46.89 | 61.13 | 38.14 |
| Extraordinary Items | -772.29 | 0 | 0 | 0 |
| 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2014 ( ₹ in Cr. ) | |
|---|---|---|---|---|
| SOURCES OF FUNDS : | ||||
| Share Capital | 2005.95 | 1939.8 | 27.22 | 1534.03 |
| Reserves and Surplus | 248.64 | 1248.87 | 1636.53 | 1010.26 |
| Total Shareholders Funds | 2254.59 | 3188.67 | 1663.75 | 2544.29 |
| Secured Loans | 607.59 | 1279.22 | 3175.99 | 2854.12 |
| Unsecured Loans | 4906.36 | 3757.21 | 3391.54 | 1744.38 |
| Total Debt | 5513.95 | 5036.43 | 6567.53 | 4598.5 |
| Total Liabilities | 7768.54 | 8225.1 | 8231.28 | 7142.79 |
| APPLICATION OF FUNDS : | ||||
| Gross Block | 3295.1 | 3287.53 | 3283.48 | 5021.26 |
| Less: Accum. Depreciation | 806.98 | 561.24 | 318.92 | 1747.42 |
| Net Block | 2488.12 | 2726.29 | 2964.56 | 3273.84 |
| Capital Work in Progress | 2503.2 | 2442.3 | 2449.75 | 2270.13 |
| Investments | 1586.45 | 1582.07 | 1552.44 | 168.91 |
| Current Assets, Loans and Advances | ||||
| Inventories | 60.93 | 703.3 | 717.53 | 634.57 |
| Sundry Debtors | 51.34 | 43.33 | 42.25 | 180.56 |
| Cash and Bank Balance | 13.28 | 16.93 | 16.64 | 17.66 |
| Loans and Advances | 1485.55 | 1153.15 | 924.51 | 666.87 |
| Less: Current Liab. and Prov. | ||||
| Current Liabilities | 420.34 | 442.27 | 436.39 | 69.75 |
| Provisions | 0 | 0 | 0 | 0 |
| Net Current Assets | 1190.76 | 1474.44 | 1264.54 | 1429.91 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 |
| Total Assets | 7768.53 | 8225.1 | 8231.29 | 7142.79 |
| Contingent Liabilities | 383.73 | 104.66 | 97.46 | 31.83 |
If I had made LUMPSUM investment of ₹ 1,00,000
in STERLING BIOTECH LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
